In 380 biopsy-naive patients with one MRI-visible prostate lesion, targeted plus perilesional biopsy was non-inferior to targeted plus systematic biopsy for Grade Group >=2 cancer detection (58% vs 58%), with fewer complications (62% vs 74%).
RCTn = 380
Deng et al. Comprehensive Evaluation of Targeted and Perilesional Biopsy in Biopsy-Naïve Patients With Prostate Positive Magnetic Resonance Imaging: PERI-PRO Noninferiority Randomized Controlled Trial